Earn rewards for your opinion on lab products.

Get exclusive insights into life science trends.

Stay up to date on research news.

New research helps scientists understand the genetic cause of immune disease
September 24, 2019 -- Research published in Nature Genetics on September 23 helps narrow down the search for molecular drivers for immune disease which could result in the identification of new drug targets and development of new therapies illnesses such as asthma, multiple sclerosis, and arthritis. Read More
Exploring new tools with class 1 CRISPR systems
September 23, 2019 -- A biomedical engineering collaboration between researchers at Duke University and North Carolina State University explores new frontiers of CRISPR technology utilizing the less well-known class 1 CRISPR system. The study was published in Nature Biotechnology on September 23. Read More
New research suggests circular RNAs are important for cardiac healing
September 20, 2019 -- Researchers from the Lewis Katz School of Medicine at Temple University describe how circular RNA fills a critical role during tissue repair after heart attacks, due to a unique ability to absorb harmful molecules. The study was published September 20 in Nature Communications. Read More
European cancer drug approvals under scrutiny for high risk of bias
September 19, 2019 -- Nearly half of all cancer drugs approved in Europe between 2014 and 2016 were deemed high risk of bias, indicating treatment effects may have been exaggerated. These were the findings of a study conducted by researchers at 7 institutions in the UK and US and published in BMJ on September 18. Read More
Personalized disease models help to fight pediatric cancers
September 19, 2019 -- Researchers at Cedars-Sinai have developed a new rapid technique the genetically modify mice to produce personalized animal models, for example, pediatric glioma. Read More
Novel "death star" nanoparticle discovered for potential use in targeted therapies
September 18, 2019 -- A novel nanoparticle has been reported by researchers at San Diego State University with the potential to serve as a delivery system for therapeutics. The research published on September 17 in eLife describes how Metamorphosis Associated Contractile structures (MACs) trigger metamorphosis in tubeworms. Moreover, they identify a novel protein (with syringe-like structures, nicknamed Death Star for the effect it has) responsible for the activation of metamorphosis. Read More
Repurposed drug shows potential to slow neurodegeneration in Parkinson's disease patients
September 17, 2019 -- Collaborative research from the University of Iowa and researchers in China and Spain, show evidence that a current drug used to treat prostate cancer may improve Parkinson's disease (PD) symptoms by slow neurodegeneration. The results from experimental models and clinical database analysis were published on September 16, in the Journal of Clinical Investigation. Read More
Chemists develop new technique to build super-active catalysts
September 13, 2019 -- New highly desirable catalysts, made mostly of precious metals, have 24 different faces that present atoms at the surface in ways that make them more catalytically active than current commercially available products. Read More
Is nanomedicine a feasible option for the pharmaceutical industry? – from the 4th Peptide Drug Design & Delivery Summit
September 12, 2019 -- The use of nanoparticles in the pharmaceutical industry is a topic of hot debate among scientists. At the 4th Annual Peptide Drug Design and Delivery Summit, August 27 -29 in Philadelphia, PA, researchers discussed the merits and challenges of incorporating these molecules into therapies. Read More
Science Board Member Spotlight: Mona Batish, PhD
September 11, 2019 -- The Science Advisory Board is pleased to bring you a new series that focuses on the most essential part of the scientific process: you! Read More
Germline genetic testing in breast cancer patients may lead to increased therapy options
September 11, 2019 -- Genetic testing for metastatic breast cancer patients may play a key role in identifying additional patients with increased risk and their response to targeted therapies. Read More
Breakthrough electrochemical technique may bring cost savings to drug companies
September 10, 2019 -- Researchers have developed a simple new method for the creation of hindered ether compounds, which are often important components of many drugs and commercial products. Hindered ethers have been traditionally difficult to manufacture, but scientists at Scripps Research have published a new electrochemistry technique in Nature on September 9, which allows these compounds to be produced faster and more efficiently. Read More
New targeted therapy for lung cancer using precious metals as Trojan exosomes
September 9, 2019 -- Researchers at the University of Edinburgh and the Universidad de Zaragoza in Spain present a novel therapeutic approach to treating cancer on September 9. The research using exosome-directed catalyst prodrug therapies was published in Nature Catalysis. Read More
The drug development industry is hungry for 3D printing – from the 4th Peptide Drug Design & Delivery Summit
September 6, 2019 -- The Science Advisory Board attended the 4th Annual Peptide Drug Design and Delivery Summit in Philadelphia from August 27 to 29. One of the most discussed topics at the event of the use of 3D printing for pharmaceutical applications. Many scientists are pursuing this technology with gusto, utilizing the technology to improve peptide drug design. Read More
Study identifies new therapeutic targets to help patients with lung cancer
September 5, 2019 -- A research team at Johns Hopkins University identified new therapeutic targets that will help increase the efficacy of current immunotherapies and reduce the side effects in patients with lung cancer. The results of this clinical study were published in The Journal of Clinical Investigation on September 4. Read More
BioTools Innovator

Conferences
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter
Latest Tweets